Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TELO

Telomir Pharmaceuticals Inc

May 29 • 04:00PM ET

1.30

+0.02 1.56 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: RNTX INDP ACIU ARTV AVXL PALI PRLD RZLT TARA GLSI

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.29	Insider Own	73.12%	Shs Outstand	34.38M	Perf Week	0.00%
Market Cap	89.41M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	18.49M	Perf Month	-10.34%
Enterprise Value	84.05M	PEG	-	EPS next Q	-	Inst Own	3.26%	Short Float	5.64%	Perf Quarter	2.36%
Income	-9.22M	P/S	-	EPS this Y	-	Inst Trans	-0.22%	Short Ratio	7.88	Perf Half Y	-0.76%
Sales	0.00M	P/B	9.01	EPS next Y	-	ROA	-293.73%	Short Interest	1.04M	Perf YTD	-2.26%
Book/sh	0.14	P/C	16.08	EPS next 5Y	-	ROE	-384.26%	52W High	3.10 -58.06%	Perf Year	-38.10%
Cash/sh	0.08	P/FCF	-	EPS past 3/5Y	-125.22% -189.25%	ROIC	-185.89%	52W Low	1.05 23.81%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.32% 5.69%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	30.88%	Oper. Margin	-	ATR (14)	0.08	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.00	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	49.88	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.00	EPS Q/Q	60.66%	SMA20	0.81%	Beta	-0.24	Target Price	8.00
Payout	-	Debt/Eq	0.04	Sales Q/Q	-	SMA50	-1.17%	Rel Volume	0.97	Prev Close	1.28
Employees	2	LT Debt/Eq	0.00	Earnings	-	SMA200	-4.46%	Avg Volume	132.35K	Price	1.30
IPO	Feb 09, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	128,293	Change	1.56%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)